Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Interest Expenses (2017 - 2026)

Ekso Bionics Holdings has reported Interest Expenses over the past 11 years, most recently at $155000.0 for Q4 2025.

  • On a quarterly basis, Interest Expenses rose 162.71% to $155000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $310000.0, a 15.24% increase, with the full-year FY2025 number at $309000.0, up 14.87% from a year prior.
  • Interest Expenses reached $155000.0 in Q4 2025 per EKSO's latest filing, up from $18000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $155000.0 in Q4 2025, with the low at $18000.0 in Q3 2025.
  • The 5-year median for Interest Expenses is $60000.0 (2023), against an average of $57550.0.
  • Peak YoY movement for Interest Expenses: skyrocketed 314.81% in 2023, then plummeted 77.22% in 2025.
  • Tracing EKSO's Interest Expenses over 5 years: stood at $36000.0 in 2021, then soared by 83.33% to $66000.0 in 2022, then changed by 0.0% to $66000.0 in 2023, then dropped by 10.61% to $59000.0 in 2024, then soared by 162.71% to $155000.0 in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $155000.0, $18000.0, and $65000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.